1.
Murano C, Igarashi A, Yamauchi K, Inoue S, Watanabe M. Osimertinib as treatment for EGFR exon 20 insertion-positive lung adenocarcinoma. EXCLI J. [Internet]. 2019 Oct. 7 [cited 2024 Mar. 28];18:893-8. Available from: https://www.excli.de/index.php/excli/article/view/1519